Recent Advances In Technology Is Expected To Favor The Growth Of Degenerative Disc Disease Treatment Market In Near Future

Google+ Pinterest LinkedIn Tumblr +

Degenerative disc disease is a spinal condition caused by the breakdown of your intervertebral discs. The symptoms observed for degenerative disc disease are tingling or numbness in legs or difficulty walking. This disease is diagnosed with physical examination, through X-rays or magnetic resonance imaging (MRI). The degenerative disc disease is most commonly seen in geriatric population and a cause of low back pain and neck pain in adults. The common cases of back pain among patients occurs at the lower side of the back and is known as lower back pain. As per American Association of Neurological Surgeons in 2016, 75-85% of people in the U.S. experience some form of back pain in their life.

Furthermore, depending upon the level of pain, degenerative disc disease can be treated by two common process which includes non-surgical and spinal fusion. The non-surgical treatments include medications, physical therapy and chiropractic care. Whereas, spinal fusion is a procedure used to surgically treat degenerative disc disease.

Get The Holistic SAMPLE With Research Methodology:

Recent advances in technology is expected to favor the growth of degenerative disc disease treatment market in near future. 

The recent advances in technology helps the degenerative disc disease treatment market to augment in near future. For instance, in 2016, according to data published in Journal of Neurosurgery: Spine, the ProDisc technology has proven clinical efficacy in the U.S. It was also found. Authors of the study found total disc replacement with ProDisc-C that the procedure is also cost-effective compared to spinal fusion and recorded an average of US $12,789 in savings which is more effective than spinal fusion for single-level procedures.

In addition to this, the manufacturers are also focusing on acquisition to adopt and strengthen the company’s product portfolio. For instance, Centinel Spine in October 2017, has entered into an asset purchase agreement to acquire the ProDisc Total Disc Replacement portfolio from DePuy Synthes. This acquisition will provide a complete platform of ProDisc technologies to Centinel Spine, which include, ProDisc-C, Discover, ProDisc-L, ProDisc-C Nova, ProDisc-C Vivo, and ProDisc-Oblique.

Get Table Of Content:


About Author

Is an excellent researcher with expertise in the healthcare domain. His detailed research on topics related to recent breakthroughs in the genetic engineering, pharmacy, and healthcare fields coupled with his ability to concise his in-depth study in the best way possible, is of great advantage to this new portal. Contact Author

Comments are closed.